2021 |
R33 |
CA251006 |
RFA-CA-20-020 |
HAUN, JERED BRACKSTON |
UNIVERSITY OF CALIFORNIA-IRVINE |
Microfluidic tumor tissue processing platform for single cell diagnostics |
Active |
2021 |
R21 |
CA236665 |
RFA-CA-20-019 |
SANTORE, MARIA M |
UNIVERSITY OF MASSACHUSETTS AMHERST |
Paper-based Breastmilk Collection System for Facile, In-Home Use |
Active |
2021 |
R33 |
CA247700 |
RFA-CA-20-018 |
JI, HANLEE P |
STANFORD UNIVERSITY |
Multimodal iterative sequencing of cancer genomes and single tumor cells |
Active |
2021 |
R33 |
CA247744 |
RFA-CA-20-018 |
GARTNER, ZEV JORDAN |
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
Universal Sample Multiplexing for Single Cell Analysis |
Active |
2021 |
R33 |
CA255893 |
RFA-CA-20-018 |
SEELIG, GEORG |
UNIVERSITY OF WASHINGTON |
Joint receptor and protein expression immunophenotyping through split-pool barcoding |
Active |
2021 |
R33 |
CA256102 |
RFA-CA-20-018 |
GREENBERG, JOEL |
DUKE UNIVERSITY |
Multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens |
Active |
2021 |
R33 |
CA257878 |
RFA-CA-20-018 |
HANSEN, ANDERS SEJR |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
Super-resolution microscopy for dynamic analysis of focal enhancer amplifications in cancer |
Active |
2021 |
R33 |
CA258016 |
RFA-CA-20-018 |
LIU, XUEFENG |
OHIO STATE UNIVERSITY |
Validating Urine Derived Cancer Cells (UDCC) -- Non-Invasive and Living Liquid Biopsies -- in Bladder Cancer Clinics |
Active |
2021 |
R21 |
CA247647 |
RFA-CA-20-017 |
WILSON, GERALD M |
UNIVERSITY OF MARYLAND BALTIMORE |
Suppressing oncogenic RNA regulons using engineered zinc finger ribonucleases |
Active |
2021 |
R21 |
CA250597 |
RFA-CA-20-017 |
ZHANG, FANGLIANG |
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE |
Targeted degradation of proteins by affinity peptide conjugated ubiquitin (APCU) |
Active |
2021 |
R21 |
CA251015 |
RFA-CA-20-017 |
STILL, AMANDA NICOLE HAYMOND |
GEORGE MASON UNIVERSITY |
New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions |
Active |
2021 |
R21 |
CA255894 |
RFA-CA-20-017 |
XIAO, HAN |
RICE UNIVERSITY |
Development of Bone-Targeting Antibodies for Ewing Sarcoma Using Genetic Code Expansion |
Active |
2021 |
R21 |
CA256081 |
RFA-CA-20-017 |
SWAGER, TIMOTHY M |
MASSACHUSETTS INSTITUTE OF TECHNOLOGY |
Innovative Droplet Lenses for NextGen Light Sensors of Biomarkers of Inflammation |
Active |
2021 |
R21 |
CA256082 |
RFA-CA-20-017 |
BAR-PELED, LIRON |
MASSACHUSETTS GENERAL HOSPITAL |
Chemical Proteomic Identification of Druggable Oncogenic Transcription Factors |
Active |
2021 |
R21 |
CA258019 |
RFA-CA-20-017 |
CHEN, KAI |
UNIVERSITY OF SOUTHERN CALIFORNIA |
Novel Bisphosphonate PET Probes for Myeloma Bone Disease |
Active |
2020 |
R33 |
CA247669 |
RFA-CA-19-022 |
HASHAM, MUNEER GULAMHUSEIN |
JACKSON LABORATORY |
Impact of Genetic Diversity on Human Xenograft Tumor Growth |
Active |
2020 |
R21 |
CA246359 |
RFA-CA-19-021 |
SEIBEL, ERIC J |
UNIVERSITY OF WASHINGTON |
Rapid Needle Biopsy Assessment at Point of Care to advance personalized cancer therapy |
Active |
2020 |
R21 |
CA251042 |
RFA-CA-19-021 |
GUPTA, GAUTAM |
UNIVERSITY OF LOUISVILLE |
Bio Cargos: Capture And Release Gels For Optimized Storage Of Cancer Biospecimens |
Active |
2020 |
R33 |
CA236681 |
RFA-CA-19-020 |
WEI, CHIA-LIN |
JACKSON LABORATORY |
Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer |
Active |
2020 |
R33 |
CA246448 |
RFA-CA-19-020 |
HALL, ADAM ROGER |
WAKE FOREST UNIVERSITY HEALTH SCIENCES |
Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores |
Active |
2020 |
R33 |
CA235294 |
RFA-CA-19-020 |
WANG, SHAOPENG |
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS |
A Virion-Display Oscillator Array and Detection Platform for Quantification of Transmembrane Protein Binding Kinetics |
Active |
2020 |
R33 |
CA240181 |
RFA-CA-19-020 |
COOKS, ROBERT GRAHAM |
PURDUE UNIVERSITY |
Advanced Development of Desorption Electrospray Ionization Mass Spectrometry for Intraoperative Molecular Diagnosis of Brain Cancer using Pathology Biopsies |
Active |
2020 |
R33 |
CA240191 |
RFA-CA-19-020 |
RECHT, MICHAEL |
PALO ALTO RESEARCH CENTER |
High-Throughput Screening Platform for Cancer Drug Discovery |
Active |
2020 |
R33 |
CA246363 |
RFA-CA-19-020 |
LEVINSON, NICHOLAS MARK |
UNIVERSITY OF MINNESOTA |
Time-resolved FRET-based allostery sensors for any protein kinase drug target |
Active |
2020 |
R33 |
CA246455 |
RFA-CA-19-020 |
CHEN, FEI |
BROAD INSTITUTE, INC. |
Clinical implementations of spatial transcriptomics in tumors |
Active |
2020 |
R33 |
CA246711 |
RFA-CA-19-020 |
FAN, RONG |
YALE UNIVERSITY |
High-throughput single-cell co-sequencing of small and large RNAs to identify molecular circuitry in cancer |
Active |
2020 |
R33 |
CA247739 |
RFA-CA-19-020 |
MATRIX BHATNAGAR, PARIJAT |
SRI INTERNATIONAL |
T-cell Biofactories For Targeting Extracellular Matrix |
Active |
2020 |
R33 |
CA240181 |
RFA-CA-19-020 |
COOKS, ROBERT GRAHAM |
PURDUE UNIVERSITY |
Advanced Development Of Desorption Electrospray Ionization Mass Spectrometry For Intraoperative Molecular Diagnosis Of Brain Cancer Using Pathology Biopsies |
Active |
2020 |
R33 |
CA236670 |
RFA-CA-19-020 |
HIGGINSON, DANIEL |
SLOAN-KETTERING INST CAN RESEARCH |
Comprehensive Breakpoint Analyses For Simultaneous Quantification Of All Dna Double Strand Break Repair Pathways |
Active |
2020 |
R33 |
CA251037 |
RFA-CA-19-020 |
WANG, SIYUAN |
YALE UNIVERSITY |
Multiplexed Imaging Of Chromatin Folding And Rna Profiles In Cancer |
Active |
2020 |
R21 |
CA229024 |
RFA-CA-19-019 |
HUR, SOOJUNG CLAIRE |
JOHNS HOPKINS UNIVERSITY |
Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy |
Active |
2020 |
R21 |
CA236612 |
RFA-CA-19-019 |
REVZIN, ALEXANDER |
MAYO CLINIC ROCHESTER |
A microfluidic cell culture platform for personalizing pancreatic cancer therapies |
Active |
2020 |
R21 |
CA236653 |
RFA-CA-19-019 |
ISSADORE, DAVID AARON |
UNIVERSITY OF PENNSYLVANIA |
High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics |
Active |
2020 |
R21 |
CA240214 |
RFA-CA-19-019 |
CICERONE, MARCUS T |
GEORGIA INSTITUTE OF TECHNOLOGY |
Label-Free Cell-Resolved Metabolomics for Tumor Microscopy |
Active |
2020 |
R21 |
CA246358 |
RFA-CA-19-019 |
SEELIG, GEORG |
UNIVERSITY OF WASHINGTON |
High-resolution spatial transcriptomics through light patterning |
Active |
2020 |
R21 |
CA247671 |
RFA-CA-19-019 |
MARTO, JARROD A |
DANA-FARBER CANCER INST |
Tools for DUB Drug Discovery |
Active |
2020 |
R21 |
CA240220 |
RFA-CA-19-019 |
ALEXANDRAKIS, GEORGIOS |
UNIVERSITY OF TEXAS ARLINGTON |
Nanotechnology Enabled Selection Of MHC-peptide Ligands To Personalize Cancer Therapy |
Active |
2020 |
R21 |
CA246457 |
RFA-CA-19-019 |
HATTORI, TAKAMITSU |
NEW YORK UNIVERSITY SCHOOL OF MEDICINE |
Rational Generation Of High-performance Recombinant Antibodies To Post-translational Modifications |
Active |
2020 |
R21 |
CA240185 |
RFA-CA-19-019 |
LI, WEI |
TEXAS TECH UNIVERSITY |
Fractionation And Profiling Of Heterogeneous Circulating Tumor Cells Using A Hyperuniform- Structured Microchip |
Active |
2020 |
R21 |
CA247638 |
RFA-CA-19-019 |
LIANG, FU-SEN |
CASE WESTERN RESERVE UNIVERSITY |
Spatiotemporal Epitranscriptome Editing Technology |
Active |
2020 |
R21 |
CA251052 |
RFA-CA-19-019 |
SHVETS, GENNADY |
CORNELL UNIVERSITY |
Phenotypic Assay For Drug Discovery And Personalized Medicine Based On Real-time Vibrational Spectroscopy Enhanced By Plasmonic Metasurfaces |
Active |
2020 |
R21 |
CA225493 |
RFA-CA-19-019 |
TEWARI, MUNEESH |
UNIVERSITY OF MICHIGAN AT ANN ARBOR |
Highly Specific, Amplification-free, Single-molecule Counting Of Rare Methylated Dna Cancer Biomarkers |
Active |
2019 |
R33 |
CA235326 |
RFA-CA-18-005 |
LEI, YUGUO |
UNIVERSITY OF NEBRASKA LINCOLN |
A Single Conical Tube Device for Precision CAR-T Cells Manufacturing |
Active |
2019 |
R21 |
CA240219 |
RFA-CA-18-004 |
ANDRES-MARTIN, LAURA |
NEW YORK STEM CELL FOUNDATION |
Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections |
Active |
2019 |
R21 |
CA236652 |
RFA-CA-18-004 |
SINGAMANENI, SRIKANTH |
WASHINGTON UNIVERSITY |
METAL-ORGANIC FRAMEWORK AS PROTECTIVE COATING FOR CANCER BIOSPECIMEN PRESERVATION |
Active |
2019 |
R33 |
CA225458 |
RFA-CA-18-003 |
KETTENBACH, ARMINJA NADINE |
DARTMOUTH COLLEGE |
Activity based profiling of Phosphoprotein phosphatases in cancer using mass spectrometry-based proteomics |
Active |
2019 |
R33 |
CA225498 |
RFA-CA-18-003 |
CHEN, SIDI |
YALE UNIVERSITY |
Rapidly scalable platforms for direct in vivo screening of functional drivers in lethal cancers |
Active |
2019 |
R33 |
CA225549 |
RFA-CA-18-003 |
TAVANA, HOSSEIN |
UNIVERSITY OF AKRON |
A High Throughput Human Tumor Modeling Technology for Cancer Drug Discovery |
Active |
2019 |
R33 |
CA229042 |
RFA-CA-18-003 |
SCHNECK, JONATHAN P |
JOHNS HOPKINS UNIVERSITY |
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells |
Active |
2019 |
R33 |
CA229068 |
RFA-CA-18-003 |
SCHIAVINATO EBERLIN, LIVIA |
UNIVERSITY OF TEXAS, AUSTIN |
Advanced Development of the MasSpec Pen for Cancer Diagnosis and Surgical Margin Evaluation |
Active |